SEVERE CHRONIC PLAQUE PSORIASIS

Clinical trials for SEVERE CHRONIC PLAQUE PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new SEVERE CHRONIC PLAQUE PSORIASIS trials appear

Sign up with your email to follow new studies for SEVERE CHRONIC PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with severe skin condition

Disease control Ongoing

This study is testing a medication called certolizumab pegol in children and teenagers aged 6 to 17 who have moderate to severe plaque psoriasis. The main goals are to understand how the drug behaves in young bodies and to check its safety. It is a Phase 3 trial, which means rese…

Matched conditions: SEVERE CHRONIC PLAQUE PSORIASIS

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

SEVERE CHRONIC PLAQUE PSORIASIS

Get alerted when new SEVERE CHRONIC PLAQUE PSORIASIS trials appear

New hope for kids with severe skin condition